We have directly monitored the kinetics of fusion of intact HIV and SIV virions with target cells by photosensitized labeling of virus-resident membrane proteins which have become part of the host cell. Due to the stochastic nature of the CD4 and coreceptor-induced triggering events leading to HIV-1 Env-mediated fusion the process is slow; the time required to reaching half-maximal fusion is about 20 min. We have dissected these steps kinetically and analyzed the molecular features of the kinetic intermediates. Kinetic studies with HIV-1 Env-expressing cells using inhibitors indicate that the HIV-1 gp41 six-helix bundle formation occurs rapidly after the engagement of gp120 by CXCR4. Our results suggest that the triggering events lead to destabilization of the membranes bearing HIV-1 Env, presumably as a result of self-insertion of the fusion peptide. We show that membrane microdomains or lipid rafts, which are specialized regions of host cell membrane enriched in glycosphingolipids, sphingomyelin and cholesterol, may play a role in organizing the viral envelope, CD4 and the appropriate chemokine receptor into a membrane fusion complex. Their role becomes crucial in primary lymphocytes, whose coreceptor levels are generally low. This process may also involve membrane signaling. The fusion reaction can be reversibly arrested at 37 0C by removal of cholesterol or glycosphingolipids from target cells, or by treatment with cytochalasin B. CXCR4 engagement and six-helix bundle formation only occurs after the release of the cytochalasin arrest. Our data indicate that a high degree of cooperativity is required to trigger the initial steps in HIV-1 Env-mediated fusion. Z01 BC 08303-28

Agency
National Institute of Health (NIH)
Institute
Division of Basic Sciences - NCI (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC008303-29
Application #
6558998
Study Section
(LECB)
Project Start
Project End
Budget Start
Budget End
Support Year
29
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Jacobs, Amy; Garg, Himanshu; Viard, Mathias et al. (2008) HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine development. Vaccine 26:3026-35
Blumenthal, Robert; Dimitrov, Dimiter S (2007) Targeting the sticky fingers of HIV-1. Cell 129:243-5
Dimitrov, Antony S; Jacobs, Amy; Finnegan, Catherine M et al. (2007) Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry 46:1398-401
Jacobs, Amy; Quraishi, Omar; Huang, Xicai et al. (2007) A covalent inhibitor targeting an intermediate conformation of the fusogenic subunit of the HIV-1 envelope complex. J Biol Chem 282:32406-13
Garg, Himanshu; Joshi, Anjali; Freed, Eric O et al. (2007) Site-specific mutations in HIV-1 gp41 reveal a correlation between HIV-1-mediated bystander apoptosis and fusion/hemifusion. J Biol Chem 282:16899-906
Fox, T E; Finnegan, C M; Blumenthal, R et al. (2006) The clinical potential of sphingolipid-based therapeutics. Cell Mol Life Sci 63:1017-23
Rawat, Satinder Singh; Viard, Mathias; Gallo, Stephen A et al. (2006) Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion. Glycoconj J 23:189-97
Finnegan, Catherine M; Blumenthal, Robert (2006) Fenretinide inhibits HIV infection by promoting viral endocytosis. Antiviral Res 69:116-23
Wexler-Cohen, Yael; Johnson, Benitra T; Puri, Anu et al. (2006) Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178. J Biol Chem 281:9005-10
Gallo, Stephen A; Wang, Wei; Rawat, Satinder S et al. (2006) Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem 281:18787-92

Showing the most recent 10 out of 42 publications